Sanofi (SNYN) - Net Assets

Latest as of March 2026: MX$73.14 Billion MXN ≈ $4.21 Billion USD

Based on the latest financial reports, Sanofi (SNYN) has net assets worth MX$73.14 Billion MXN (≈ $4.21 Billion USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (MX$128.02 Billion ≈ $7.37 Billion USD) and total liabilities (MX$54.88 Billion ≈ $3.16 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check SNYN intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	MX$73.14 Billion
% of Total Assets	57.13%
Annual Growth Rate	1.93%
5-Year Change	3.88%
10-Year Change	24.23%
Growth Volatility	4.37

Sanofi - Net Assets Trend (2013–2025)

This chart illustrates how Sanofi's net assets have evolved over time, based on quarterly financial data. See how many days can Sanofi fund operations to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Sanofi (2013–2025)

The table below shows the annual net assets of Sanofi from 2013 to 2025. For live valuation and market cap data, see SNYN market cap overview.

Year	Net Assets	Change
2025-12-31	MX$71.71 Billion ≈ $4.13 Billion	-7.90%
2024-12-31	MX$77.86 Billion ≈ $4.48 Billion	+4.71%
2023-12-31	MX$74.35 Billion ≈ $4.28 Billion	+1.14%
2022-12-31	MX$73.51 Billion ≈ $4.23 Billion	+6.49%
2021-12-31	MX$69.03 Billion ≈ $3.97 Billion	+9.32%
2020-12-31	MX$63.15 Billion ≈ $3.63 Billion	+6.83%
2019-12-31	MX$59.11 Billion ≈ $3.40 Billion	+0.12%
2018-12-31	MX$59.03 Billion ≈ $3.40 Billion	+1.33%
2017-12-31	MX$58.26 Billion ≈ $3.35 Billion	+0.93%
2016-12-31	MX$57.72 Billion ≈ $3.32 Billion	-0.83%
2015-12-31	MX$58.21 Billion ≈ $3.35 Billion	+3.45%
2014-12-31	MX$56.27 Billion ≈ $3.24 Billion	-1.34%
2013-12-31	MX$57.03 Billion ≈ $3.28 Billion	--

Equity Component Analysis

This analysis shows how different components contribute to Sanofi's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 0.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Other Components	MX$71.38 Billion	100.00%
Total Equity	MX$71.38 Billion	100.00%

Sanofi Competitors by Market Cap

The table below lists competitors of Sanofi ranked by their market capitalization.

Company	Market Cap
Marriott International Inc NASDAQ:MAR	$104.47 Billion
Sanofi F:SNW2	$104.50 Billion
Medtronic plc SA:MDTC34	$104.84 Billion
Mizuho Financial Group Inc. NYSE:MFG	$105.19 Billion
GlaxoSmithKline plc MX:GSKN	$104.06 Billion
AIR LIQUIDE ADR 1/5/EO 11 F:AILA	$103.86 Billion
INTESA SANPAOLO ADR/6 F:IESJ	$103.85 Billion
State Bank of India NSE:SBIN	$103.33 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Sanofi's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 77,507,000,000 to 71,376,000,000, a change of -6,131,000,000 (-7.9%).
Net income of 7,813,000,000 contributed positively to equity growth.
Dividend payments of 4,772,000,000 reduced retained earnings.
Share repurchases of 5,030,000,000 reduced equity.
New share issuances of 177,000,000 increased equity.
Other factors decreased equity by 4,319,000,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	MX$7.81 Billion	+10.95%
Dividends Paid	MX$4.77 Billion	-6.69%
Share Repurchases	MX$5.03 Billion	-7.05%
Share Issuances	MX$177.00 Million	+0.25%
Other Changes	MX$-4.32 Billion	-6.05%
Total Change	MX$-	-7.91%

Book Value vs Market Value Analysis

This analysis compares Sanofi's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 12.78x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 16.31x to 12.78x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2017-12-31	MX$46.32	MX$755.29	x
2018-12-31	MX$47.27	MX$755.29	x
2019-12-31	MX$47.00	MX$755.29	x
2020-12-31	MX$50.37	MX$755.29	x
2021-12-31	MX$54.83	MX$755.29	x
2022-12-31	MX$58.01	MX$755.29	x
2023-12-31	MX$59.17	MX$755.29	x
2024-12-31	MX$61.83	MX$755.29	x
2025-12-31	MX$59.10	MX$755.29	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Sanofi utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 10.95%
The company shows good efficiency in utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 16.72%
• Asset Turnover: 0.37x
• Equity Multiplier: 1.78x
Recent ROE (10.95%) is above the historical average (9.21%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2013	6.53%	11.88%	0.33x	1.69x	MX$-1.97 Billion
2014	7.82%	13.72%	0.33x	1.74x	MX$-1.22 Billion
2015	7.39%	12.30%	0.34x	1.76x	MX$-1.52 Billion
2016	8.18%	13.57%	0.33x	1.82x	MX$-1.05 Billion
2017	14.52%	23.30%	0.36x	1.72x	MX$2.63 Billion
2018	7.31%	12.07%	0.32x	1.89x	MX$-1.58 Billion
2019	4.76%	7.46%	0.33x	1.91x	MX$-3.09 Billion
2020	19.55%	32.95%	0.33x	1.82x	MX$6.01 Billion
2021	9.06%	15.89%	0.33x	1.75x	MX$-645.10 Million
2022	9.19%	14.81%	0.36x	1.70x	MX$-594.40 Million
2023	7.29%	12.98%	0.33x	1.71x	MX$-2.00 Billion
2024	7.17%	12.55%	0.33x	1.71x	MX$-2.19 Billion
2025	10.95%	16.72%	0.37x	1.78x	MX$675.40 Million

Industry Comparison

This section compares Sanofi's net assets metrics with peer companies in the Drug Manufacturers - General industry.

Industry Context

Industry: Drug Manufacturers - General
Average net assets among peers: $36,943,000,000
Average return on equity (ROE) among peers: 12.89%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Sanofi (SNYN)	MX$73.14 Billion	6.53%	0.75x	$104.14 Billion
AstraZeneca PLC (AZNN)	$14.60 Billion	9.15%	3.21x	$290.50 Billion
GlaxoSmithKline plc (GSKN)	$21.34 Billion	20.55%	2.71x	$104.06 Billion
Novartis AG (NVSN)	$74.89 Billion	8.96%	0.74x	$281.45 Billion

About Sanofi

MX:SNYN Mexico Drug Manufacturers - General

Market Cap

$104.14 Billion

MX$1.81 Trillion MXN

Market Cap Rank

#237 Global

#8 in Mexico

Share Price

MX$755.29

Change (1 day)

-0.09%

52-Week Range

MX$736.00 - MX$955.00

All Time High

MX$1212.00